Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Trial of Tetrathiomolybdate (TM) in Primary Biliary Cirrhosis

NCT00805805 is registered in ClinicalTrials.gov with George Brewer as lead sponsor.

NCT NCT00805805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00805805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Trial of Tetrathiomolybdate (TM) in Primary Biliary Cirrhosis
Lead sponsor
George Brewer
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2006
Completion date
December 31, 2008
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary biliary cirrhosis